Loading...
Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
BACKGROUND: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. METHODS: CD133+ HPCs were isolated and purified from human...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690192/ https://ncbi.nlm.nih.gov/pubmed/33243165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07633-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|